Lelieveld Irene M, Böttcher Anna, Hennermann Julia B, Beck Michael, Fellgiebel Andreas
Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Villa Metabolica, Center for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
PLoS One. 2015 Sep 4;10(9):e0137603. doi: 10.1371/journal.pone.0137603. eCollection 2015.
Brain structural alterations and neuropsychiatric symptoms have been described repeatedly in Fabry disease, yet cognitive deficits have been shown to be only mild. Here, we aimed to investigate neuropsychiatric symptoms and brain structure longitudinally. We expected no clinically relevant increase of neuropsychiatric symptoms in parallel to increased brain structural alterations. We assessed 14 Fabry patients (46.1 ± 10.8 years) who had participated in our investigation eight years ago. Patients engaged in neuropsychiatric testing, as well as structural magnetic resonance imaging and angiography to determine white matter lesions, hippocampal volume, and the diameter of the larger intracranial arteries. While Fabry patients did not differ on cognitive performance, they showed progressive and significant hippocampal volume loss over the 8-year observation period. White matter lesions were associated with older age and higher white matter lesion load at baseline, but did not reach statistical significance when comparing baseline to follow-up. Likewise, intracranial artery diameters did not increase significantly. None of the imaging parameters were associated with the neuropsychiatric parameters. Depression frequency reduced from 50% at baseline to 21% at follow-up, but it did not reach significance. This investigation demonstrates clinical stability in cognitive function, while pronounced hippocampal atrophy is apparent throughout the 8 years. Our middle-aged Fabry patients appeared to compensate successfully for progressive hippocampal volume loss. The hippocampal volume decline indicates brain regional neuronal involvement in Fabry disease.
在法布里病中,脑结构改变和神经精神症状已被反复描述,然而认知缺陷仅表现为轻度。在此,我们旨在纵向研究神经精神症状和脑结构。我们预计神经精神症状不会随着脑结构改变的增加而出现临床上相关的增加。我们评估了14名8年前参与我们研究的法布里病患者(46.1±10.8岁)。患者接受了神经精神测试以及结构磁共振成像和血管造影,以确定白质病变、海马体积和颅内较大动脉的直径。虽然法布里病患者在认知表现上没有差异,但在8年的观察期内,他们的海马体积出现了渐进性且显著的减少。白质病变与年龄较大以及基线时较高的白质病变负荷相关,但在比较基线和随访时未达到统计学显著性。同样,颅内动脉直径也没有显著增加。没有一个成像参数与神经精神参数相关。抑郁频率从基线时的50%降至随访时的21%,但未达到显著性。这项研究表明认知功能具有临床稳定性,而在整个8年期间明显存在明显的海马萎缩。我们的中年法布里病患者似乎成功地代偿了渐进性的海马体积减少。海马体积下降表明法布里病中脑区神经元受累。